ScholarIQanswers from OpenAlex
Chronic Lymphocytic Leukemia Research
TopicLeading institutions, researchers & key papers
Chronic Lymphocytic Leukemia Research is a topic indexed in ScholarIQ from OpenAlex.
What is known about Chronic Lymphocytic Leukemia Research?
ScholarIQrecord summary
This cluster of papers focuses on the genomic aberrations, treatment strategies, and prognostic factors associated with chronic lymphocytic leukemia (CLL). It covers topics such as the use of BTK inhibitors (e.g., Ibrutinib), the role of rituximab, TP53 mutations, and the impact of immunoglobulin mutations. Additionally, it explores therapeutic targets and outcomes in patients with Waldenström macroglobulinemia.
How many works does Chronic Lymphocytic Leukemia Research have?
ScholarIQindexed works
Chronic Lymphocytic Leukemia Research has 252 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Chronic Lymphocytic Leukemia Research?
ScholarIQopenalex
The OpenAlex for Chronic Lymphocytic Leukemia Research is on the source record.
What are the most-cited papers on Chronic Lymphocytic Leukemia Research?
ScholarIQmost cited works
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
Michael Hallek, Kirsten Fischer, Guenter Fingerle-Rowson, AM Fink, R. Busch, Jiřı́ Mayer, M. Hensel, Georg Hopfinger, G Hess, Ulrich von Grünhagen, Michèle Bergmann, J. Catalano, Pier Luigi Zinzani, Federico Caligaris‐Cappio, JF Seymour, A Berrébi, Ulrich Jäger, Bruno Cazin, Marek Trněný, Anne Westermann, C-M Wendtner, BF Eichhorst, Peter Staib, Andreas Bühler, Dirk Winkler, Thorsten Zenz, Sebastian Böttcher, Matthias Ritgen, Myriam Mendila, Michael Kneba, Hartmut Döhner, S. Stilgenbauer
A family of human cdc2‐related protein kinases.
Matthew Meyerson, G H Enders, Chia‐Ling Wu, Li Su, Claude Gorka, C. Nelson, Ed Harlow, Li‐Huei Tsai
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Yair Herishanu, Patricia Pérez‐Galán, Delong Liu, Angélique Biancotto, Stefania Pittaluga, Bérengère Vire, Federica Gibellini, Ndegwa Njuguna, Elinor Lee, Lawrence Stennett, Nalini Raghavachari, Poching Liu, J. Philip McCoy, Mark Raffeld, Maryalice Stetler‐Stevenson, Constance M. Yuan, Richard M. Sherry, Diane C. Arthur, Irina Marić, Therese White, Gerald E. Marti, Peter J. Munson, Wyndham H. Wilson, Adrian Wiestner
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
Constantine S. Tam, Susan O’Brien, William G. Wierda, Hagop M. Kantarjian, Sijin Wen, Kim‐Anh Do, Deborah A. Thomas, Jörge E. Cortes, Susan Lerner, Michael J. Keating
<i>TP53</i> Mutation and Survival in Chronic Lymphocytic Leukemia
Thorsten Zenz, Barbara Eichhorst, Raymonde Busch, Tina Denzel, Sonja Häbe, Dirk Winkler, Andreas Bühler, Jennifer Edelmann, Manuela Bergmann, Georg Hopfinger, Manfred Hensel, Michael Hallek, Hartmut Döhner, Stephan Stilgenbauer
Where is Chronic Lymphocytic Leukemia Research research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Chronic Lymphocytic Leukemia Research is open access?
ScholarIQopen access share
60%OPEN ACCESS